Schedule & Agenda

Below is the 2020 schedule and agenda for the BIO CEO & Investor Conference. 

BIO CEO & Investor Conference
Date
  • Show All
Time
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Jump to Day
  • Show All
Monday, February 10
9:00 AM - 9:55 AM
As PD-1/L1 checkpoint inhibitors continue to reveal new tumor types those drugs can attack…
11:00 AM - 11:55 AM
Small and mid-sized biotech companies commercially launched 42% of U.S. new drug approvals in 2018,…
1:30 PM - 2:25 PM
Approximately 5% of people in the U.S. are at risk for NASH and it is on track to be the dominant…
2:30 PM - 3:25 PM
Polls of U.S. public confidence in prescription drug companies have dropped so far that multiple…
3:30 PM - 4:25 PM
Fewer than 20 gene therapies have so far been approved in the global market. With more than 750…
4:30 PM - 5:45 PM
Despite a record number of large deals across the pharmaceutical and biotechnology landscape,…
Tuesday, February 11
9:00 AM - 9:55 AM
According to the World Health Organization, cardiovascular diseases are the leading cause of death…
10:00 AM - 10:55 AM
Barbara Dalton, PhD is Vice President, WWBD and Senior Managing Partner of Pfizer Ventures. Barbara…
11:00 AM - 11:55 AM
Dr. Love joined GBT in June 2014 as president and chief executive officer with broad leadership and…
12:00 PM - 12:55 PM
As the Principal Deputy Commissioner of Food and Drugs, Dr. Amy P. Abernethy, M.D., Ph.D., helps…
1:00 PM - 1:55 PM
BIO in partnership with the Center for Talent Innovation will launch the first report on building…
2:00 PM - 2:55 PM
Michael M. Morrissey, Ph.D., is President and Chief Executive Officer at Exelixis and a member of…
3:00 PM - 3:55 PM
In recent months, the exits of several large companies from the neuroscience space, optimistic…
4:00 PM - 4:55 PM
With the close out of 2019 at record levels and 2020 in full swing, the biotechnology sector has…
Wednesday, February 12
8:30 AM - 1:00 PM
The course is an optional registration add-on for the BIO CEO & Investor Conference, but conference…
Not Yet Scheduled
[Not Yet Scheduled]
AiCure uses artificial intelligence to see, hear and understand how people respond to treatment…
AIMM is an antibody discovery and development company. We select antibodies directly from cured…
We leverage our expertise in high-purity cell manufacturing to develop novel therapies in a range…
Altimmune is a publicly traded (Nasdaq: ALT) clinical stage biopharmaceutical company focused on…
Amplyx is focused on the development of innovative therapies for debilitating and life-threatening…
Our Mission: Improve Public Health by Reducing Addiction. Amygdala is developing ANS-6637 which…
The company is a clinical stage oncology company. The lead program is a next generation ROS1/NTRK…
Anima Biotech is advancing Translation Control Therapeutics, the first and only platform for the…
APRINOIA Therapeutics is a clinical stage biotech company headquartered in Taipei. The company is…
Aptorum Group Limited (Nasdaq: APM) is a pharmaceutical company dedicated to developing and…
Aptose Biosciences is a clinical-stage biotechnology company with an initial focus on hematology…
We are developing an entirely novel class of orally available small molecule to address currently…
Asimov is developing a mammalian synthetic biology platform for next-generation therapeutics. The…
Atreca is a biopharmaceutical company utilizing its differentiated platform to discover and develop…
aTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines…
AZTherapies is a leader in innovation, using a differentiated approach that recognizes…
Boundless Bio, a San Diego based company backed by ARCH Venture Partners, City Hill Ventures,…
BrainStorm Cell Therapeutics, Inc. is a clinical-stage, publicly-traded biotechnology company…
With Groundbreaking AI, Breakthrough Genomics aims to achieve the impossible: transform the way…
Caladrius is a late-stage therapeutics development biopharmaceutical company pioneering…
Cancer Prevention Pharmaceuticals, Inc. is developing novel therapeutic agents that make possible…
Catalyst Pharmaceuticals is dedicated to advancing therapies targeting rare neuromuscular and…
CEL-SCI believes that boosting a patient's immune system while it is still intact should provide…
Celavie Biosciences is a privately-held company whose mission is to improve lives and restore hope…
Cellectar Biosciences is focused on the discovery, development and commercialization of drugs for…
Cerevance is a private pharmaceutical company focused on central nervous system diseases. The…
Cernostics is leading the way in the third revolution in pathology – AI-driven image analysis of…
CerSci Therapeutics is developing non-opioids for the treatment of pain. With a focus on…
ChemioCare is a biotechnology company focused on improving the profiles of approved medicines by…
Dedicated to Developing Treatments that Restore and Preserve Vision for People with Serious Eye…
CohBar (NASDAQ: CWBR) is a clinical stage biotechnology company focused on the research and…
Concarlo Holdings, LLC is a startup biotechnology company, developing diagnostics and therapeutics…
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing cancer…
CytoDel has developed proprietary technology that enables recombinant derivatives of botulinum…
Cytonus Therapeutics is an early stage Biotechnology that is focusing on immuneotherapies for…
We believe that the next frontier in immunotherapy will harness the power of Natural Killer Cells…
Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of…
DeckTherapeutics is currently developing THDG3 a novel, patent protected omega-3 diglyceride…
We are a global biotechnology company focused on further improving and leveraging the patented and…
We are an Oxford, UK-based business with a revolutionary computer-based platform and a unique…
eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the…
Eleusis is a clinical stage life science company dedicated to unlocking the therapeutic potential…
ENB Therapeutics is a privately held, clinical stage company founded in 2015 and located in NYC. We…
Enesi Pharma is an innovative pharmaceutical company developing novel products with potential to…
Staccato alprazolam is an investigational drug designed to be used as a single-use, epileptic…
Envisagenics integrates proprietary machine learning algorithms, high performance computing, and…
EpiVax Oncology, a precision cancer immunotherapy company, is developing mutanome-directed, neo…
Evonetix is developing a radically different approach to gene synthesis – a highly parallel desktop…
EyeGate is a clinical-stage pharmaceutical company focused on developing products for treating…
FSD Pharma is a specialty biotech pharmaceutical company that is advancing the research and…
Gain Therapeutics SA is a preclinical biotech company specializing in the discovery of new drugs…
Gero is an AI-driven drug discovery platform. Our AI platform is next-generation comparing to what…
Glycostem Therapeutics is developing off-the-shelf allogeneic cellular immunotherapy to treat…
Glysantis is a pre-clinical stage biotechnology company developing first-in-class nanomedicines to…
Goldilocks Therapeutics was formed in 2018 to develop preventatives and/or treatments for acute…
Greenwich LifeSciences (GLS) is a private biopharmaceutical company located in Houston, TX that is…
Ichor Biologics is a pre-clinical, NYC-based biotechnology company that has validated a novel…
ImmunoMet is a clinical stage biotech targeting cellular metabolism to develop novel anti-tumor and…
We are a clinical stage biopharmaceutical company focusing on solid tumor cancers with an initial…
Inflection Biosciences Ltd, based in Dublin, is developing small molecule therapeutics for the…
Intract is a technology company transitioning to product development. Lead product, ready for Phase…
JHL Biotech was founded in 2012 with a vision of making biopharmaceuticals affordable and…
Kineta, Inc. is a clinical stage biotechnology company committed to developing disruptive life…
I. Kymeris is at Discovery Stage in proprietary cellular immunotherapy vaccines active against…
Libera Bio ™ is a US-European biopharma preclinical-stage company leveraging IP from the…
Matricelf is a pioneering biotechnology company developing a platform for autologous matrix and…
CARMA(TM) is an mRNA-based proprietary therapeutic platform for autologous cell therapy for the…
MedicaSafe is a developer of data-generating medication products, a convergence of drugs/device…
MetVital is a clinical-stage, metabolic therapy company developing first-in-class, broadly…
Mogrify is a pre-clinical stage cell therapy company. The company has developed a proprietary…
Molecular Theranostics, LLC (MT or the Company) was formed in January 2014 in the state of Ohio…
Mucpharm is a privately owned biotech company based in Sydney, Australia focused on the therapy of…
Since 1950, we've spearheaded efforts to transform the lives of people with muscular dystrophy, ALS…
NeuroRx has developed a platform of NMDA/5-HT2A dual-targeted CNS drugs to treat suicidal Bipolar…
Newron (SIX: NWRN, XETRA: NP5) is a biopharmaceutical company focused on the development of novel…
Novadip is a clinical-stage biopharmaceutical company leveraging its unique tissue regeneration…
Olipass is a South Korea based biotech company who develops innovative antisense nucleic acid (ASO)…
OncoCell is a privately held immunogenomic ‘liquid biopsy’ platform company focused on early…
Oragenics, Inc. is focused on becoming a leader in novel antibiotics against infectious disease…
Oramed Pharmaceuticals is a platform technology pioneer in the field of oral delivery solutions for…
OriCiro Genomics is a cell-free genome technology company. The company offers the next-generation…
Oriel Research Therapeutics’ primary mission is to address the challenge of early diagnosis and…
Origenis GmbH is a privately-held German biopharmaceutical company with a proprietary platform for…
Founded in 2000 in Barcelona, Spain, Oryzon Genomics – ORY (ISIN Code: ES0167733015) is a clinical…
Outlook Therapeutics is a late clinical stage biopharmaceutical company working to develop the…
Oxidien Pharmaceuticals is a Phase II-ready company that address an unmet need in kidney disease…
PainQx is an A.I. powered digital medical device company that has developed a method to objectively…
Founded by world-renowned computational and experimental RNA biologists, Panorama integrates…
Pattern Pharma's P2PAR product activates the innate immune system (dendritic cells, macrophages and…
PDS Biotech is a clinical stage immuno-oncology company with a growing pipeline of immunotherapies…
Phanes Therapeutics is an emerging leader in innovative drug discovery in immuno-oncology and eye…
PHD Biosciences is a clinical stage biotechnology company developing prescription and non…
The Company is engaged in the clinical development of PT-112, a first-in-class pyrophosphate…
Pipeline Therapeutics is a clinical-stage, biopharmaceutical company focused on the development and…
Praetego Inc. is a preclinical pharma company in Durham, NC. With proprietary small molecules,…
Protalix is a biopharmaceutical company focused on the development and commercialization of…
Quadrant Biosciences is an epigenetic diagnostics company with an initial focus on the early…
Redx Pharma plc is an exciting UK-based biotech focused on developing novel precision medicines to…
ReForm Biologics is developing a proprietary pipeline of its own patented biologic formulations…
Rezolute is a clinical-stage biotech developing transformative therapies for rare and metabolic…
Ripple Therapeutics is a spin out from Interface Biologics following the successful sale of their…
Founded in 2017, spun out of HealthTell in 2018, and now based in San Carlos, CA - RubrYc…
Salarius Pharmaceuticals, Inc. is focused on developing novel epigenetic therapies to treat high…
Samus Therapeutics is a privately held Boston-based biopharmaceutical company developing novel…
Serimmune is an immune intelligence company focused on providing a holistic view of adaptive immune…
SmartPharm Therapeutics is a privately-held, development-stage pharmaceutical company focused on…
Company Focus: SPI is developing the first therapeutics for the prevention and treatment of…
Step Pharma is a biotechnology company discovering and developing proprietary small molecule…
Summit Therapeutics is a leader in antibiotic innovation. Our new mechanism antibiotics are…
Synthetic Biologics, Inc. is a diversified clinical-stage company leveraging the microbiome to…
Synthis is a pre-seed company based at Alexandria LaunchLabs-NYC incubator, developing a first in…
TargetGene Biotechnologies has developed and is now seeking to commercialize the most precise and…
Teon Therapeutics is a private biopharma company developing a novel pipeline of GPCR-targeting…
Thoth Science Inc., a Korean startup, aims to be a clinical stage bio-pharmaceutical focused on…
Tonix is a clinical-stage biopharmaceutical company focused on discovering and developing small…
Trovagene is a clinical stage company developing targeted therapeutics to treat solid tumor and…
twoXAR is a pharmaceutical company with the vision to become the global leader in drug discovery…
VBL Therapeutics, is a clinical stage bio-pharmaceutical company focused on the discovery,…
Venatorx Pharmaceuticals, Inc. is a private pharmaceutical company focused on the discovery and…
VerImmune is an Immune-Oncology company developing a breakthrough therapy known as Anti-Tumor…
The current PROM (Premature Rupture of Membrane) testing market is estimated at about $1.1B per…
XyloCor Therapeutics is a biopharmaceutical company focused on the development of novel gene…
At Zikani , we bring RARE thinking for RARE solutions. We are leveraging our proprietary TURBO-ZM…